Studies shed light on risks and trends in pediatric antipsychotic prescribing.

摘要

STUDIES CONTINUE TO DOCUMENT worrisome trends in pediatric an-tipsychotic prescribing, as evidence builds about the risks of substantial weight gain and emergent metabolic problems in children and adolescents who take these drugs. Moreover, the studies suggest physicians may be missing opportunities to minimize the drugs' risks.